 Eosinophilic fasciitis distinguishable eosinophilia-myalgia syndrome L-tryptophan use Induration skin majority patients eosinophilia-myalgia syndrome L-tryptophan bears clinical histopathological resemblance fasciitis EF similarities suggestion eosinophilia-myalgia syndrome EF disease relationship eosinophilia-myalgia syndrome EF prevalence L-tryptophan use cohort patients EF clinical laboratory findings patients eosinophilia-myalgia syndrome cutaneous involvement None patients EF L-tryptophan preparations onset illness Marked clinical laboratory test differences patients EF eosinophilia-myalgia syndrome Patients eosinophilia-myalgia syndrome acute onset severe symptoms frequency rash pulmonary cardiac gastrointestinal neurologic myopathic thyroid involvement patients EF Corticosteroid therapy improvement cutaneous involvement patients EF successful patients eosinophilia-myalgia syndrome Hospitalization fatalities patients eosinophilia-myalgia syndrome observations eosinophilia-myalgia syndrome severe disease multisystemic involvement EF contrast eosinophilia-myalgia syndrome EF L-tryptophan ingestion